SCHEMBL17014306

SCHEMBL17014306

CC1CCc2c(C(=O)COC(=O)C3CCCC3)ccc(C3CCC(C(=O)COC(=O)C4CCCC4)CC3)c21

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 1/20 0.41
SENP8 Q96LD8 1/20 0.41
SENP7 Q9BQF6 1/20 0.41
SENP6 Q9GZR1 1/20 0.41
NPC1 O15118 3/20 0.39
ALDH1A1 P00352 6/20 0.36
RAB9A P51151 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
HTT P42858 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
TSHR P16473 1/20 0.36
MDM2 Q00987 1/20 0.36
ALOX15 P16050 1/20 0.36
RECQL P46063 1/20 0.35
ATM Q13315 1/20 0.35
HPGD P15428 1/20 0.35
TDP1 Q9NUW8 1/20 0.34
RXFP1 Q9HBX9 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16577469 0.82 CASP3 (0.42) CASP3SENP8SENP7SENP6NPC1
SCHEMBL16577448 0.80 CASP3 (0.41) CASP3SENP8SENP7SENP6NPC1
SCHEMBL17014360 0.79 CASP3 (0.38) CASP3SENP8SENP7SENP6NPC1
SCHEMBL15746315 0.78 CASP3 (0.39) CASP3SENP8SENP7SENP6NPC1
SCHEMBL17014307 0.77 NOTUM (0.32)
SCHEMBL17014308 0.70 NOTUM (0.37) ALDH1A1HPGD
SCHEMBL15746323 0.63 CASP3 (0.45) CASP3SENP8SENP7SENP6NPC1
SCHEMBL7603312 0.60 NPC1 (0.50) CASP3SENP8SENP7SENP6NPC1
SCHEMBL17281354 0.60 ALDH1A1 (0.63) NPC1ALDH1A1RAB9ASMN1; SMN2HTT
SCHEMBL4637935 0.59 RAB9A (0.58) CASP3SENP8SENP7SENP6NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150232509-A1 SPIRO RING COMPOUNDS AS HEPATITIS C VIRUS (HCV) INHIBITORS SUNSHINE LAKE PHARMA CO., LTD. (CN) 2015-08-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150232509-A1 SPIRO RING COMPOUNDS AS HEPATITIS C VIRUS (HCV) INHIBITORS HAVCR2, SLC10A1, SORD CASP3 1392/4885SENP8 1669/4885SENP7 2596/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.